Medical Device Priority Approval
On September 30, 2020, CMDE issued a notification that the “Soft Contact Lens” of CooperVision Inc. and “Ceftazidime/avibatan Concentration Gradient AGAR Diffusion Strip” of BIOMERIEUX S.A. are proposed to obtain the priority pathway approval because the “Soft Contact Lens” specially designed for children has obvious clinical advantages and the “Ceftazidime/avibatan Concentration Gradient AGAR Diffusion Strip” is listed in the national key research and development plan. Priority pathway could accelerate the technical review from CMDE and shorten the registration timeline. China Med Device could help evaluate and offer support on priority registration.